Cost of Human Immunodeficiency Virus (HIV) and Determinants of Healthcare Costs in HIV-Infected Treatment-Naive Patients Initiated on Antiretroviral Therapy in Germany: Experiences of the PROPHET Study-Reference-Cited by-同舟云学术

Cost of Human Immunodeficiency Virus (HIV) and Determinants of Healthcare Costs in HIV-Infected Treatment-Naive Patients Initiated on Antiretroviral Therapy in Germany: Experiences of the PROPHET Study

Published:2020-10 Issue:10 Volume:23 Page:1324-1331
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Valbert Frederik,Wolf Eva,Schewe Knud,Klauke Stephan,Hanhoff Nikola,Hoffmann Christian,Preis Stefan,Pahmeier Kathrin,Wasem Jürgen,Neumann Anja

Funder

Janssen-Cilag GmbH

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference25 articles.

1. Schätzung der Zahl der HIV-Neuinfektionen und der Gesamtzahl von Menschen mit HIV in Deutschland;an der Heiden;Epid Bull,2019

2. Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study;Mostardt;Eur J Health Econ,2013

3. Analysis of contemporary HIV/AIDS health care costs in Germany: driving factors and distribution across antiretroviral therapy lines;Treskova;Medicine (Baltimore),2016

4. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy;Rodger;JAMA,2016

5. Antiretroviral therapy for the prevention of HIV-1 transmission;Cohen;N Engl J Med,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of HIV in people with potential HIV-indicator conditions in Germany: an analysis of data from statutory health insurances;eClinicalMedicine;2024-07

2. A Qualitative Look at Decreasing Barriers to Receiving Uninterrupted Care for People Living with HIV in Rural Southern Georgia;Open Journal of Nursing;2024

3. Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP study;Archives of Public Health;2023-08-25

4. Socio-demographic and psycho-social determinants of HIV late presentation in Germany – results from the FindHIV study;AIDS Care;2023-03-13

5. Healthcare Resource Consumption and Related Costs in Patients on Antiretroviral Therapies: Findings from Real-World Data in Italy;International Journal of Environmental Research and Public Health;2023-02-21